Table: begin end state 1 19 non-cytoplasmic 20 37 transmembrane 38 46 cytoplasmic 47 78 transmembrane 79 94 non-cytoplasmic 95 114 transmembrane 115 125 cytoplasmic 126 153 transmembrane 154 234 non-cytoplasmic 235 260 transmembrane 261 290 cytoplasmic 291 315 transmembrane 316 320 non-cytoplasmic 321 338 transmembrane 339 349 cytoplasmic 350 373 transmembrane 374 378 non-cytoplasmic 379 401 transmembrane 402 403 cytoplasmic 404 428 transmembrane 429 432 non-cytoplasmic 433 454 transmembrane 455 472 cytoplasmic 473 495 transmembrane 496 501 non-cytoplasmic
Input: >HSERO_RS04820 FitnessBrowser__HerbieS:HSERO_RS04820 MLAQLKAAFKYFNDAVPFKLVPALIATAVLIALLLTPCPTGLEPKAWALVAIFLTTIVAI ILKVMPIGVMAMMAIVIVSLSQVTSTSSKGAITDALASFSNPLIWLIVVAILISRGLKKT GLGRRVGLMFIALLGKRTIGIGYGLAICELVLAPFTPSNTARGGGIVHPIMKSIANAFDS DPAKGTQNKVGSYLALVNYHANPITSAMFLTATAPNPLVVNYVAKATGHALQLTWTTWAL CMLLPGLVCLLIMPMVIYLLSPPELKSTPNAVDYARSELDKMGKLGASEKVMLGTFALLL LLWANVPAMLLGAAFTLDPTVVAFVGLFVLIITGTIDWDDVLSEKSAWDTLVWFGALVML AEQLNKTGVVAWFSEGMKAAIVASGMGWIAVAAVLLLVFVLSHYFFASTTAHISAMMLAF LTVGAQLLPPQYVVPFMLMMTAGSGVMMTLTHYATGTSPIIFGSGYVSMGKWWGVGFVMA VVELLVFATVGMVWWKGLGYW
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server